These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 1333678)

  • 1. Low p53 protein expression in salivary gland tumours compared with lung carcinomas.
    Soini Y; Kamel D; Nuorva K; Lane DP; Vähäkangas K; Pääkkö P
    Virchows Arch A Pathol Anat Histopathol; 1992; 421(5):415-20. PubMed ID: 1333678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and mutations of p53 in salivary gland tumours.
    Kärjä VJ; Syrjänen KJ; Kurvinen AK; Syrjänen SM
    J Oral Pathol Med; 1997 May; 26(5):217-23. PubMed ID: 9178173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical detection of E-cadherin in certain types of salivary gland tumours.
    Andreadis D; Epivatianos A; Mireas G; Nomikos A; Poulopoulos A; Yiotakis J; Barbatis C
    J Laryngol Otol; 2006 Apr; 120(4):298-304. PubMed ID: 16623973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-erbB-2 oncogene expression in salivary gland tumours.
    Kärjä V; Syrjänen S; Kataja V; Syrjänen K
    ORL J Otorhinolaryngol Relat Spec; 1994; 56(4):206-12. PubMed ID: 7915830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunophenotypical profiles of salivary gland tumours: a new evidence for their histogenetic origin.
    Gürbüz Y; Yildiz K; Aydin O; Almaç A
    Pathologica; 2006 Apr; 98(2):147-52. PubMed ID: 16929788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PCNA, Ki-67 and p53 expressions in submandibular salivary gland tumours.
    Alves FA; Pires FR; De Almeida OP; Lopes MA; Kowalski LP
    Int J Oral Maxillofac Surg; 2004 Sep; 33(6):593-7. PubMed ID: 15308260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of hMSH2 and hMLH1 proteins of the human DNA mismatch repair system in salivary gland tumors.
    Castrilli G; Fabiano A; La Torre G; Marigo L; Piantelli C; Perfetti G; Ranelletti FO; Piantelli M
    J Oral Pathol Med; 2002 Apr; 31(4):234-8. PubMed ID: 12076327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness.
    Sugano S; Mukai K; Tsuda H; Hirohashi S; Furuya S; Shimosato Y; Ebihara S; Takeyama I
    Laryngoscope; 1992 Aug; 102(8):923-7. PubMed ID: 1353853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric analysis of DNA content and Ki-67-positive fractions in the diagnosis of salivary gland tumors.
    Horii A; Yoshida J; Sakai M; Okamoto S; Kubo T
    Eur Arch Otorhinolaryngol; 1998; 255(5):265-8. PubMed ID: 9638470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human α-defensin (DEFA) gene expression helps to characterise benign and malignant salivary gland tumours.
    Winter J; Pantelis A; Kraus D; Reckenbeil J; Reich R; Jepsen S; Fischer HP; Allam JP; Novak N; Wenghoefer M
    BMC Cancer; 2012 Oct; 12():465. PubMed ID: 23050799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor (VEGF) expression and microvascular density in salivary gland tumours.
    Faur AC; Lazar E; Cornianu M
    APMIS; 2014 May; 122(5):418-26. PubMed ID: 23937241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma.
    Prasad AR; Savera AT; Gown AM; Zarbo RJ
    Arch Pathol Lab Med; 1999 Sep; 123(9):801-6. PubMed ID: 10458827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of malignant grade of salivary gland tumors: studies by cytofluorometric nuclear DNA analysis, histochemistry for nucleolar organizer regions and immunohistochemistry for p53.
    Ishii K; Nakajima T
    Pathol Int; 1994 Apr; 44(4):287-96. PubMed ID: 8044296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Over-expression of glutathione S-transferases, DT-diaphorase and an apparently tumour-specific cytosolic class-3 aldehyde dehydrogenase by Warthin tumours and mucoepidermoid carcinomas of the human parotid gland.
    Sreerama L; Sladek NE
    Arch Oral Biol; 1996 Jun; 41(6):597-605. PubMed ID: 8937651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of p63 isotypes (DeltaN and TA) in salivary gland neoplasms: biological and diagnostic implications.
    Maruya S; Kies MS; Williams M; Myers JN; Weber RS; Batsakis JG; El-Naggar AK
    Hum Pathol; 2005 Jul; 36(7):821-7. PubMed ID: 16084953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and mutation patterns of p53 in benign and malignant salivary gland tumors.
    Nordkvist A; Röijer E; Bang G; Gustafsson H; Behrendt M; Ryd W; Thoresen S; Donath K; Stenman G
    Int J Oncol; 2000 Mar; 16(3):477-83. PubMed ID: 10675478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glial Fibrillary Acidic Protein Expression Helps Distinguish Pleomorphic Adenoma from Histologic Mimics.
    Gorski Z; Purgina B; Wasserman JK
    Head Neck Pathol; 2022 Sep; 16(3):695-702. PubMed ID: 35064902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-myc, ras p21 and p53 expression in pleomorphic adenoma and its malignant form of the human salivary glands.
    Deguchi H; Hamano H; Hayashi Y
    Acta Pathol Jpn; 1993; 43(7-8):413-22. PubMed ID: 8396843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA ploidy analysis in salivary gland tumours by image cytometry.
    Vargas PA; Torres-Rendon A; Speight PM
    J Oral Pathol Med; 2007 Jul; 36(6):371-6. PubMed ID: 17559500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.
    Edwards PC; Bhuiya T; Kelsch RD
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):613-9. PubMed ID: 15153875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.